Serina Therapeutics, Inc. (SER): Capital Expenditures
$59.0K
Year ended 2025-12-31
$66.0K
Trailing 12 months to 2026-06-30
+24.2%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $59.0K | +168.2% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $22.0K | -95.6% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $504.0K | n/a | 2025-03-24, From 2023-01-01 |
| No annual figure between 2020-12-31 and 2023-12-31. | |||
| 2020-12-31 | $20.0K | -96.9% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $641.0K | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $21.0K | n/m | 2020-03-31, From 2018-01-01 |
| 2017-12-31 | $1.0K | n/a | 2019-04-01, From 2017-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $59.0K | +168.2% |
| iBio, Inc. (IBIO) | 2026-06-30 | $578.0K | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $28.0K | n/a |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $104.0K | +845.5% |
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $8.0K | -97.1% |
| Clene Inc. (CLNN) | 2025-12-31 | $39.0K | +160.0% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $285.7K | -41.4% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $434.0K | -42.1% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $0 | -100.0% |
Compare SER, IBIO, LSTA, ATNM side by side · Screen every company in Pharmaceutical Preparations ↗